| http://www.w3.org/ns/prov#value | - The list of cancerswhere EGFRvIII is found will probably grow afterimplementation of more sensitive methods such as RT-PCR, RNase protection assays and specific monoclonalantibodies.The use of EGFR specific antibodies used for cancertherapy is promising, but serious problems can be envi-sioned, due to heterogeneity within the tumour, and thefact that normal cells also express EGFR. Therefore, itwi
|
